{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:03:19Z","timestamp":1779688999512,"version":"3.53.1"},"reference-count":42,"publisher":"Informa UK Limited","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nucleosides, Nucleotides &amp; Nucleic Acids"],"DOI":"10.1080\/15257770.2026.2662373","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:18:36Z","timestamp":1779686316000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Gene therapy, RNA-based drugs, and CRISPR in neuroprotection"],"prefix":"10.1080","author":[{"given":"Aleena","family":"Taufiq","sequence":"first","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad Ahmad","family":"Dar","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health Sciences, Jazan University","place":["Jazan, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Singh","sequence":"additional","affiliation":[{"name":"Delhi Technological University","place":["Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Jawed","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health Sciences, Jazan University","place":["Jazan, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Singh","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"key":"e_1_3_3_2_1","first-page":"340","article-title":"RNA-Based Therapies for Neurodegenerative Diseases","volume":"118","author":"Ayala Y. M.","year":"2021","unstructured":"Ayala, Y. M.; Nguyen, A. D. RNA-Based Therapies for Neurodegenerative Diseases. Mo. Med. 2021, 118, 340\u2013345.","journal-title":"Mo. Med."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.25259\/AUJMSR_20_2025"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1515255"},{"key":"e_1_3_3_5_1","article-title":"Gene Editing in Neurological Disorders: Role of CRISPR-Cas9 in Targeted Therapies","volume":"18","author":"Aminabee S.","year":"2025","unstructured":"Aminabee, S.; Chaitanya, M. M.; Begum, M. A.; Jonnalagadda, S. K.; Devi, M. S.; Thanmai, P. Gene Editing in Neurological Disorders: Role of CRISPR-Cas9 in Targeted Therapies. Biomed. Pharmacol. J. 2025, 18(October Spl Edition).","journal-title":"Biomed. Pharmacol. J."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2016.00123"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.032"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0183-8"},{"key":"e_1_3_3_9_1","article-title":"AAV-Mediated Gene Therapy for the CNS: The Case for Early Treatment","volume":"33","author":"Vidal L. E.","year":"2025","unstructured":"Vidal, L. E.; Martinez-Navio, J. M. AAV-Mediated Gene Therapy for the CNS: The Case for Early Treatment. Mol. Ther. Methods Clin. Dev. 2025, 33, 101640.","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"e_1_3_3_10_1","unstructured":"AskBio Inc. First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson\u2019s Disease [Internet]. Research Triangle Park NC: AskBio; 22 Sep 2025 cited 2026 Jan 11]. Available from: https:\/\/www.askbio.com\/first-european-participants-randomized-in-askbio-phase-2-gene-therapy-trial-of-ab-1005-for-parkinsons-disease\/."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2025.1004119"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09521-6"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S457393"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1853"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ggn2.202500010"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.385285"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115283"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186116"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2025.022"},{"key":"e_1_3_3_20_1","volume-title":"TL mRNA Therapeutics for Neurological Diseases and Pain [Internet]","author":"TriLink BioTechnologies","unstructured":"TriLink BioTechnologies. TL mRNA Therapeutics for Neurological Diseases and Pain [Internet]. San Diego, CA: TriLink BioTechnologies [cited 2025 Dec 6]. Available from: https:\/\/www.trilinkbiotech.com\/blog\/mrna-therapeutics-for-neurological-diseases-and-pain\/."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/bkcs.70083"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.52965\/001c.24934"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/17582024.2024.2402216"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-022-00519-9"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081790"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-026-00925-5"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105055"},{"key":"e_1_3_3_28_1","first-page":"567","article-title":"CRISPR\/Cas9 Genome Editing for Neurodegenerative Diseases","volume":"22","author":"Nojadeh J. N.","year":"2023","unstructured":"Nojadeh, J. N.; Eryilmaz, N. S.; Erg\u00fcder, B. \u0130. CRISPR\/Cas9 Genome Editing for Neurodegenerative Diseases. EXCLI J. 2023, 22, 567.","journal-title":"EXCLI J."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes16080850"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbaf024"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101305"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(23)00227-0"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102634"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02237-2"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01103-1"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.07.014"},{"key":"e_1_3_3_37_1","first-page":"JE01","article-title":"A Scoping Review on the Ethical Issues in the Use of CRISPR-Cas9 in the Creation of Human Disease Models","volume":"17","author":"Ru D.","year":"2023","unstructured":"Ru, D.; MathEw, M.; SuRapanEni, K. M. A Scoping Review on the Ethical Issues in the Use of CRISPR-Cas9 in the Creation of Human Disease Models. J. Clin. Diagn. Res. 2023, 17, JE01\u2013JE08.","journal-title":"J. Clin. Diagn. Res."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312485"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3906\/biy-1912-52"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70577"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.373658"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1527242"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-025-10884-x"}],"container-title":["Nucleosides, Nucleotides &amp; Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15257770.2026.2662373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:18:37Z","timestamp":1779686317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15257770.2026.2662373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":42,"alternative-id":["10.1080\/15257770.2026.2662373"],"URL":"https:\/\/doi.org\/10.1080\/15257770.2026.2662373","relation":{},"ISSN":["1525-7770","1532-2335"],"issn-type":[{"value":"1525-7770","type":"print"},{"value":"1532-2335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lncn20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lncn20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}